Arkolith/Insider Trading/ZVRA/Form 4

Schafer Joshua

CCO & EVP, Bus. DevelopmentZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Feb 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2025Option exercise(M)35K——40K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2025Option exercise(M)35K—$071K
Jan 30, 2025Grant(A)68K—$068K
Jan 30, 2025Grant(A)34K—$034K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-002627) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML